GSE212231 GSE218491 SHP2 inhibition 2 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE212231_GSE218491_SHP2 inhibition_2_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE212231_GSE218491_SHP2 inhibition_2_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE212231_GSE218491_SHP2 inhibition_2_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE212231_GSE218491_SHP2 inhibition_2_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

Rho GTPase activating protein 23

Gene

gametogenetin binding protein 2

Gene

PDCD6IP pseudogene 2

Gene

SDA1 domain containing 1 pseudogene 1

Gene

napsin B aspartic peptidase (pseudogene)

Gene

BAZ2B antisense RNA 1

Gene

transmembrane protein 191A (pseudogene)

Gene

RAB11B antisense RNA 1

Gene

keratin 8 pseudogene 46

Gene

DIRAS family GTPase 1

  • Gene

    Rho GTPase activating protein 23


  • Gene

    gametogenetin binding protein 2


  • Gene

    PDCD6IP pseudogene 2


  • Gene

    SDA1 domain containing 1 pseudogene 1


  • Gene

    napsin B aspartic peptidase (pseudogene)


  • Gene

    BAZ2B antisense RNA 1


  • Gene

    transmembrane protein 191A (pseudogene)


  • Gene

    RAB11B antisense RNA 1


  • Gene

    keratin 8 pseudogene 46


  • Gene

    DIRAS family GTPase 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.